Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides—a new target for the design of antitumor and antiglaucoma drugs?
- 18 January 2005
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 15 (4) , 963-969
- https://doi.org/10.1016/j.bmcl.2004.12.053
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Pyrroloquinolone PDE5 Inhibitors with Improved Pharmaceutical Profiles for Clinical Studies on Erectile DysfunctionJournal of Medicinal Chemistry, 2004
- Hypoxia activates the capacity of tumor‐associated carbonic anhydrase IX to acidify extracellular pHFEBS Letters, 2004
- Therapeutic applications of sulfamatesExpert Opinion on Therapeutic Patents, 2004
- Carbonic Anhydrase Inhibitors. Design of Selective, Membrane-Impermeant Inhibitors Targeting the Human Tumor-Associated Isozyme IXJournal of Medicinal Chemistry, 2004
- Carbonic anhydrase inhibitors: The first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IXBioorganic & Medicinal Chemistry Letters, 2004
- Review ArticleJournal of Enzyme Inhibition and Medicinal Chemistry, 2004
- Indisulam: an anticancer sulfonamide in clinical developmentExpert Opinion on Investigational Drugs, 2003
- Effects of von Hippel-Lindau gene mutation and methylation status on expression of transmembrane carbonic anhydrases in renal cell carcinomaZeitschrift für Krebsforschung und Klinische Onkologie, 2002
- Expression of a Novel Transmembrane Carbonic Anhydrase Isozyme XII in Normal Human Gut and Colorectal TumorsThe American Journal of Pathology, 2000
- Carbonic anhydrase inhibitors. Part 61. Quantum chemical QSAR of a group of benzenedisulfonamidesEuropean Journal of Medicinal Chemistry, 1999